Vietnam Health Official Concerned About Safety Of GSK H1N1 Vaccine
This article was originally published in PharmAsia News
Executive Summary
A Vietnamese health official said he is concerned about possible cases of anaphylaxis and other severe adverse effects from the 1.2 million doses of H1N1 flu vaccine ordered